BidaskClub upgraded shares of Cognex (NASDAQ:CGNX) from a strong sell rating to a sell rating in a report published on Tuesday morning, BidAskClub reports.

A number of other brokerages have also commented on CGNX. Zacks Investment Research lowered Cognex from a buy rating to a sell rating in a research note on Tuesday, April 23rd. Gordon Haskett assumed coverage on Cognex in a research note on Wednesday, April 17th. They set a hold rating and a $54.00 price target on the stock. Sanford C. Bernstein lowered Cognex from an outperform rating to a market perform rating and set a $46.00 price target on the stock. in a research note on Tuesday, April 30th. They noted that the move was a valuation call. Needham & Company LLC lowered Cognex from a buy rating to a hold rating in a research note on Tuesday, April 30th. Finally, ValuEngine raised Cognex from a sell rating to a hold rating in a research note on Monday, February 25th. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and two have given a buy rating to the company’s stock. Cognex has an average rating of Hold and a consensus target price of $52.20.

Shares of CGNX stock opened at $45.47 on Tuesday. Cognex has a 12 month low of $34.88 and a 12 month high of $59.18. The stock has a market cap of $7.60 billion, a PE ratio of 36.67, a PEG ratio of 2.91 and a beta of 2.02. The company has a current ratio of 8.31, a quick ratio of 7.46 and a debt-to-equity ratio of 0.01.

Cognex (NASDAQ:CGNX) last announced its quarterly earnings results on Monday, April 29th. The scientific and technical instruments company reported $0.19 EPS for the quarter, beating the Zacks’ consensus estimate of $0.16 by $0.03. Cognex had a return on equity of 18.90% and a net margin of 26.55%. The firm had revenue of $173.50 million for the quarter, compared to analyst estimates of $172.16 million. During the same period last year, the firm posted $0.21 earnings per share. The business’s revenue for the quarter was up 2.3% on a year-over-year basis. Equities analysts predict that Cognex will post 1.02 EPS for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, May 31st. Investors of record on Friday, May 17th were paid a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.44%. The ex-dividend date was Thursday, May 16th. Cognex’s dividend payout ratio is currently 16.13%.

In related news, insider John J. Curran sold 50,000 shares of Cognex stock in a transaction that occurred on Friday, May 3rd. The stock was sold at an average price of $49.01, for a total value of $2,450,500.00. Following the transaction, the insider now directly owns 12,500 shares of the company’s stock, valued at $612,625. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 5.60% of the stock is owned by insiders.

Several institutional investors have recently bought and sold shares of the stock. Iberiabank Corp lifted its stake in Cognex by 3.8% in the first quarter. Iberiabank Corp now owns 6,224 shares of the scientific and technical instruments company’s stock valued at $317,000 after buying an additional 229 shares during the period. Candriam Luxembourg S.C.A. lifted its stake in Cognex by 2.9% in the first quarter. Candriam Luxembourg S.C.A. now owns 8,859 shares of the scientific and technical instruments company’s stock valued at $451,000 after buying an additional 248 shares during the period. Private Capital Group LLC lifted its stake in Cognex by 50.7% in the first quarter. Private Capital Group LLC now owns 847 shares of the scientific and technical instruments company’s stock valued at $43,000 after buying an additional 285 shares during the period. Bronfman E.L. Rothschild L.P. lifted its stake in Cognex by 9.6% in the fourth quarter. Bronfman E.L. Rothschild L.P. now owns 3,822 shares of the scientific and technical instruments company’s stock valued at $148,000 after buying an additional 335 shares during the period. Finally, Private Advisor Group LLC lifted its stake in Cognex by 3.9% in the first quarter. Private Advisor Group LLC now owns 8,927 shares of the scientific and technical instruments company’s stock valued at $454,000 after buying an additional 335 shares during the period. 94.53% of the stock is currently owned by institutional investors.

About Cognex

Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate tasks primarily in manufacturing processes worldwide. It provides machine vision products, which are used to automate the manufacture and tracking of discrete items, including mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.

Read More: What is an SEC Filing?

Analyst Recommendations for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.